Nuvelo(NUVO) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nuvelo(NUVO)

NUVO 0.170

+169,917.0%

Aug 30 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: rkrw who wrote (125)	12/12/2006 11:10:02 AM
From: tuck	Read Replies (2) of 140

Color from Bloomberg, courtesy of spartex at IHub, with analyst comments on remaining pipe: investorshub.com Note the contrasting views by the two analysts regarding rNAPc2. I happen to agree with (holding nose) Aschoff. The Pacific Growth analyst seems unconcerned about the "wash-out" problem, the FDA questions, and the antibody response to rNAPc2. Anybody here know what NUVO has done to address these issues? They might have said something, but I don't follow the company. Anyhow, this has the whiff of Pacific Growth angling for the business of doing NUVO's next offering. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next